J. Feighner

发表

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

G. Dunbar, J. Cohn, L. Fabre, 1991, British Journal of Psychiatry.

Serotonin-1A anxiolytics: an overview.

J. Feighner, W. Boyer, 1989, Psychopathology.

Overview of USA controlled trials of trazodone in clinical depression

J. Feighner, W. Boyer, 2004, Psychopharmacology.

Diagnostic criteria for use in psychiatric research.

J. Feighner, S. Guze, E. Robins, 1972, Archives of general psychiatry.

A double-blind comparative trial with mianserin and amitriptyline in outpatients with major depressive disorders.

J. Feighner, R. S. Jacobs, R. Jackson, 1983, British journal of clinical pharmacology.

Selective Serotonin Re-Uptake Inhibitors: The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline

J. Feighner, W. Boyer, 1991 .

An overview of paroxetine.

J. Feighner, W. Boyer, Boyer Wf, 1992, The Journal of clinical psychiatry.

A 102-center prospective study of seizure in association with bupropion.

J. Feighner, J. Ascher, C. Lineberry, 1991, The Journal of clinical psychiatry.

A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks

J. Feighner, S. Silberstein, A. Getson, 1998, Neurology.

A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients.

J. Feighner, W. Boyer, R. Weisler, 1990, The Journal of clinical psychiatry.

Bupropion in tricyclic antidepressant nonresponders with unipolar major depressive disorder.

J. Feighner, J. Ascher, J. Apter, 1994, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Overview of antidepressants currently used to treat anxiety disorders.

J. Feighner, 1999, The Journal of clinical psychiatry.

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.

J. Feighner, K. Overø, 1999, The Journal of clinical psychiatry.

Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients

J. Feighner, L. Sverdlov, G. Nicolau, 2008, International clinical psychopharmacology.

A double‐blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders

J. Feighner, C. Merideth, 1983, Acta psychiatrica Scandinavica. Supplementum.

Fluoxetine-induced weight loss in overweight non-depressed humans.

J. Feighner, J. Ferguson, 1987, International journal of obesity.

A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.

J. Feighner, G. Hendrickson, C. Merideth, 1984, The Journal of clinical psychiatry.

A controlled trial of adinazolam versus desipramine in geriatric depression.

J. Feighner, W. Boyer, V. Doroski, 1990, International clinical psychopharmacology.

Selective serotonin re-uptake inhibitors : advances in basic research and clinical practice

J. Feighner, W. Boyer, 1996 .

A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness

J. Feighner, A. Gelenberg, B. Weiss, 1979, Psychopharmacology.

Nosology of primary affective disorders and application to clinical research

J. Feighner, 1981, Acta psychiatrica Scandinavica. Supplementum.

A placebo‐controlled double‐blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder

J. Feighner, W. Boyer, 1993, International clinical psychopharmacology.

Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspirone.

J. Cohn, J. Feighner, 1989, Neuropsychobiology.

An Overview of Fluoxetine in Geriatric Depression

J. Feighner, W. Boyer, G. Hendrickson, 1988, British Journal of Psychiatry.

A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression.

J. Feighner, B. Leonard, L. Sverdlov, 2000, Journal of affective disorders.

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

Norma Pugh, P. Murali Doraiswamy, Madhukar H. Trivedi, 2002, JAMA.

Mechanism of action of antidepressant medications.

J. Feighner, 1999, The Journal of clinical psychiatry.

A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.

J. Feighner, S. Targum, M. Bennett, 1998, The Journal of clinical psychiatry.

Venlafaxine: a new dimension in antidepressant pharmacotherapy.

J. Feighner, S. Montgomery, A. Frazer, 1993, The Journal of clinical psychiatry.

Clinical significance of early non‐response in depressed patients

J. Feighner, W. Boyer, 1994 .

Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.

J. Feighner, Warren C. Stern, L. Miller, 1986, Journal of clinical psychopharmacology.

Tricyclic antidepressants and monoamine oxidase inhibitors.

J. Feighner, E. Robins, M. Schuckit, 1971, Archives of general psychiatry.

The diagnosis of depression

J. Feighner, W. Boyer, 1991 .

Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.

J. Cohn, J. Feighner, 1985, The Journal of clinical psychiatry.

Distinct mechanism for antidepressant activity by blockade of central substance P receptors.

R G Hill, David J. Smith, J. Feighner, 1998, Science.

ELECTROSLEEP THERAPY: A Controlled Double Blind Study

J. Feighner, S. Brown, J. Olivier, 1973, The Journal of nervous and mental disease.

Electrosleep therapy: current usage in psychiatry.

J. Feighner, 1971, California medicine.

The role of venlafaxine in rational antidepressant therapy.

J. Feighner, 1994, The Journal of clinical psychiatry.

Maintenance Antidepressant Therapy: A Double-Blind Comparison of Trazodone and Imipramine

J. Feighner, G. Hendrickson, C. Merideth, 1981 .

Antidepressants: Past, Present and Future

J. Feighner, S. Preskorn, R. Ross, 2004, Handbook of Experimental Pharmacology.

Clinical overview of serotonin re-uptake inhibitors

J. Feighner, 1992 .

Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Combination Therapy in the Treatment of Depression

J. Feighner, E. Robins, M. Schuckit, 1971 .

Venlafaxine for treatment-resistant unipolar depression.

J. Feighner, A. Nierenberg, J. Cole, 1994, Journal of clinical psychopharmacology.

Bupropion: a review of its mechanism of antidepressant activity.

J. Feighner, H. Fibiger, W. Potter, 1995, The Journal of clinical psychiatry.

Cost Analysis of Paroxetine versus Imipramine in Major Depression

J. Feighner, J. Bentkover, 1995, PharmacoEconomics.

A family study of Gilles de la Tourette syndrome.

J. Feighner, M. Schuckit, N. Frost, 1976, Diseases of the nervous system.

Cardiovascular safety in depressed patients: focus on venlafaxine.

J. Feighner, 1995, The Journal of clinical psychiatry.

Long-term therapy for depression with trazodone.

L. Fabre, J. Feighner, 1983, The Journal of clinical psychiatry.

Double-blind comparison of bupropion and fluoxetine in depressed outpatients.

J. Feighner, E. A. Gardner, J. Ascher, 1991, The Journal of clinical psychiatry.

Impact of anxiety therapy on patients' quality of life.

J. Feighner, 1987, The American journal of medicine.

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial

J. Feighner, J. Ferguson, P. Keck Jr, 1998, Psychopharmacology.

Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.

J. Feighner, K. Rickels, W. Smith, 1985, Archives of general psychiatry.

Comparison of alprazolam, imipramine, and placebo in the treatment of depression.

L. Fabre, J. Feighner, K. Rickels, 1983, JAMA.

Pilot study of alpidem, a novel imidazopyridine compound, in anxiety.

J. Feighner, T. Venable, N. Manowitz, 1988, Psychopharmacology bulletin.

Promising new directions in antidepressant development

J. Feighner, W. Boyer, V. Garlapati, 2004 .

A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression.

J. Feighner, W. Boyer, R. Fowler, 1989, Psychopharmacology bulletin.

Double-blind multicenter comparison of fluvoxamine versus sertraline in the treatment of depressed outpatients

J. Feighner, C. Nemeroff, J. Ballenger, 1995 .

Adverse consequences of fluoxetine-MAOI combination therapy.

J. Feighner, W. Boyer, R. Neborsky, 1990, The Journal of clinical psychiatry.

Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.

J. Feighner, K. Rickels, E. Schweizer, 1994, The Journal of clinical psychiatry.

Hormonal potentiation of imipramine and ECT in primary depression.

J. Feighner, M. Schuckit, J. Croughan, 1972, The American journal of psychiatry.

A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.

J. Feighner, G. Hendrickson, C. Merideth, 1982, The Journal of clinical psychiatry.

Clinical Effects of the 5‐HT1A Partial Agonists in Depression: A Composite Analysis of Buspirone in the Treatment of Depression

L. Fabre, J. Feighner, K. Rickels, 1990, Journal of clinical psychopharmacology.

A double‐blind comparison of alprazolam Vs. imipramine and placebo in the treatment of major depressive disorder

J. Feighner, S. Chammas, G. Hendrickson, 1983, Acta psychiatrica Scandinavica.

Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.

J. Feighner, N. Damlouji, Feighner Jp, 1985, The Journal of clinical psychiatry.

Paroxetine in the treatment of depression: a comparison with imipramine and placebo

J. Feighner, W. Boyer, 1989, Acta psychiatrica Scandinavica. Supplementum.

Benzodiazepines as Antidepressants

J. Feighner, 1982 .

A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.

L. Fabre, J. Feighner, K. Rickels, 1998, The Journal of clinical psychiatry.

Citalopram treatment of fluoxetine nonresponders.

J. Feighner, M. Thase, R. Lydiard, 2001, The Journal of clinical psychiatry.

Cluster analysis of clinical data to identify subtypes within a study population following treatment with a new pentapeptide antidepressant.

John F. Noble, J. Feighner, L. Sverdlov, 2000, The international journal of neuropsychopharmacology.

Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder.

J. Feighner, R. Shrivastava, S. Montgomery, 2006, The international journal of neuropsychopharmacology.

Eﬃcacy and safety of 30 mg/d and 45 mg/d nemiﬁtide compared to placebo in major depressive disorder

J. Feighner, R. Shrivastava, S. Montgomery, 2006 .

Antidepressants in the Treatment of Depression

J. Feighner, W. Boyer, 1990 .

Nosology: a voice for a systematic data-oriented approach.

J. Feighner, 1979, The American journal of psychiatry.

Multimodality treatment of the hyperkinetic child.

J. Feighner, A. Feighner, 1974, The American journal of psychiatry.

Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.

J. Cohn, J. Feighner, R. Fieve, 1992, The Journal of clinical psychiatry.

The new generation of antidepressants.

J. Feighner, 1983, The Journal of clinical psychiatry.

Discriminant analysis to separate a study population by treatment subgroups in a pilot clinical trial with a new pentapeptide antidepressant (INN 00835)

J. Feighner, L. Sverdlov, G. Nicolau, 2001, European Neuropsychopharmacology.

Clinical Efficacy of the Newer Antidepressants

J. Feighner, 1981 .

Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.

J. Feighner, A. Entsuah, M. McPherson, 1998, Journal of affective disorders.

Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression

J. Feighner, L. Sverdlov, A. Kastin, 2001, International clinical psychopharmacology.

A Double‐Blind Comparison of Paroxetine With Imipramine in the Long‐Term Treatment of Depression

J. Feighner, J. Claghorn, 1993, Journal of clinical psychopharmacology.

A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.

J. Feighner, W. Boyer, C. Merideth, 1989, International clinical psychopharmacology.

A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.

J. Feighner, 1985, The Journal of clinical psychiatry.

A study comparing paroxetine placebo and imipramine in depressed patients.

G. Dunbar, J. Cohn, L. Fabre, 1993, Journal of affective disorders.

Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.

J. Feighner, D. Dunner, J. Davidson, 1994, Journal of clinical psychopharmacology.

Trazodone, a triazolopyridine derivative, in primary depressive disorder.

J. Feighner, 1980, The Journal of clinical psychiatry.

Pharmacology: New Antidepressants

J. Feighner, 1980 .

Long-Term Safety and Clinical Acceptability of: Venlafaxine and Imipramine in Outpatients

J. Feighner, R. Shrivastava, J. Davidson, 1994 .

Comparisons of Maprotiline with Imipramine in Severe Depression: A Multicenter Controlled Trial

J. Feighner, J. Logue, B. Sachais, 1979, Journal of clinical pharmacology.

The effect of treatment with a new antidepressant: INN 00835 on platelet serotonin uptake in depressed patients

J. Feighner, B. Leonard, L. Sverdlov, 1998, European Neuropsychopharmacology.

The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients.

J. Feighner, J. Kelly, B. Leonard, 1999 .

A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.

J. Feighner, W. Boyer, G. Hendrickson, 1989, International clinical psychopharmacology.

Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression

J. Feighner, D. Overstreet, G. Nicolau, 2004, Psychopharmacology.

Open label study of alprazolam in severely depressed inpatients.

J. Feighner, 1983, The Journal of clinical psychiatry.

A double-blind study of bupropion and placebo in depression.

J. Feighner, Warren C. Stern, L. Miller, 1984, The American journal of psychiatry.